The idea of reopening the economy is somewhat of a misnomer. The economy will not return to normal all at once, and there is a clear risk of a second wave of the pandemic coming with the relaxation of shelter-in-place orders around the country. Since some governors are in the process of relaxing these restrictions, we thought this is the perfect opportunity to discuss the risks around those decisions. … READ MORE >
Health care
New relief is approved for hospitals, but challenges remain
Over the past few weeks, we have been reaching out to our clients as well as hosting several virtual CFO Forums. Through those interactions, our clients in the health care sector have been painting a grim picture of the financial effects of the coronavirus. … READ MORE >
Some hospitals could be left out as second round of Provider Relief Fund is distributed
Not all hospitals benefited equally when the initial $30 billion of the Provider Relief Fund was distributed. Now, with the second round of funding set to go out, some health care providers – especially hospitals organized as governmental entities — could again be left out. … READ MORE >
Wearables and the fight against COVID-19
As COVID-19 continues to spread around the world, research organizations are trying to leverage wearable technology and crowd-source data to aid in the fight against the global pandemic … READ MORE >
Amid disruption in health care, private equity is poised to put its cash to work
As the world approaches 1.5 million confirmed coronavirus cases and more than 80,000 deaths, the financial and operational toll of quarantine efforts will create opportunities for both strategic and financial buyers across industries, including health care. … READ MORE >
Cybersecurity, amid coronavirus, remains a top risk in health care
Cybersecurity remains a top risk within the health care industry as attackers are weaponizing COVID-19 and breaches continue to increase during the first quarter of 2020. … READ MORE >
Coronavirus pandemic highlights importance of life sciences industry
While the coronavirus pandemic has slowed growth in the life sciences sector this year, it has also highlighted the importance of the biotech and pharmaceutical industries as the whole world battles the COVID-19 disease and its impacts. This industry focus could have a lasting impact in shifting consumer and policymaker … … READ MORE >
Life sciences industry growth was on a strong trajectory. Then the coronavirus pandemic hit.
Strong consumer spending, historically low unemployment and an easing of trade tensions with China initially fueled optimism early in the year for a 2020 bull market. But as the coronavirus pandemic has upended the global economy, uncertainty and disruption have replaced that once sunny outlook, and the life sciences ecosystem … … READ MORE >
How health care systems, dependent on outsourcing, can adjust to India’s stay-at-home order
Over the past several years, many health care providers and payers have outsourced business functions to India. But there was a risk that many could not have predicted: That a pandemic would force employees to work from home. … READ MORE >
How health systems can manage the financial impact of the coronavirus
The effects of the coronavirus on health systems will be far-reaching and long-lasting. Beyond the impact on front-line staff and the disruption of having many employees work remotely, health systems are also seeing a cloud loom when it comes to their finances. To seek relief from these headwinds, the chief … … READ MORE >